Vascular Calcification: Clinical Trials

19 trials for Vascular Calcification, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed, 4 unknown, 3 not yet recruiting, 1 active not recruiting. 19 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable19Completed 9, Unknown 4, Not yet recruiting 3, Active not recruiting 1, Recruiting 1, Withdrawn 1

Follow Vascular Calcification: new trials by email Literature Review of Vascular Calcification trials Research Report on Vascular Calcification

Trials (filtered) newest first · largest first

All 19 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Analysis of the Influence of Dialysis Fluid Composition on Vascular Calcification in Patients With Chronic Kidney Disease Undergoing Hemodialysis
Citrate dialysate with magensium supplementation, Acetate dialysate - Vascular Calcification, Hemodialysis
Not applicableNot yet recruitingHospital Clinic of Barcelona802027-01-022026-09-16
Comparison of RA-IVL and RA-SHP in Calcified Coronary Lesions
Super High-Pressure Non-Compliant Balloon, Intravascular Lithotripsy System - Vascular Calcification
Not applicableNot yet recruitingLin Zhao1622026-01-012025-12-29
A Study to Evaluate the Safety and Effectiveness of the FastWave Artero™ Peripheral Intravascular Lithotripsy (IVL) System in Adults With Peripheral Artery Disease (PAD)
FastWave Artero™ Peripheral IVL System - Peripheral Artery Disease (PAD)
Not applicableNot yet recruitingFastWave Medical1102025-12-012025-10-09
Mammography and Breast Arterial Calcification: An Information-Sharing Trial
BAC-Enhanced Letter, Waitlist Control - Mammography, Vascular Calcification
Not applicableActive not recruitingIcahn School of Medicine at Mount Sinai54922021-09-292026-04-16
SOLUTION Trial in China
Shockwave Medical Peripheral Intravascular Lithotripsy (IVL) System M5 & S4 - Peripheral Arterial Disease, Calcifications Vascular
Not applicableUnknownGenesis Medtech Corporation202021-06-152022-06-28
Effect of Citrate Dialysate on Vascular Calcification
Citrate Dialysate, Standard Dialysate - Vascular Calcification
Not applicableCompletedEmory University542021-05-272026-05-05
SOLSTICE Trial in China
Shockwave Coronary Intravascular Lithotripsy (IVL) System C2 - Coronary Artery Disease, Calcifications Vascular
Not applicableUnknownGenesis Medtech Corporation202021-04-152022-06-27
Modulation of Vascular Calcification in Chronic Dialysis Patients
Medium Cut-Off (MCO) dialysis membrane, High-Flux dialysis membrane - Vascular Calcification
Not applicableCompletedCharite University, Berlin, Germany502018-01-222020-01-23
Pilot Medical Evaluation of the T50 Test
T50 Calcification Inhibition Test (CIT) - Renal Failure, Cardiovascular Diseases
Not applicableCompletedFresenius Medical Care Deutschland GmbH7762017-09-222022-02-09
Gemigliptin and Biomarkers of Kidney Injury and Vascular Calcification
Gemigliptin - Diabetic Nephropathies
Not applicableCompletedBangkok Metropolitan Administration Medical College and Vajira Hospital2012017-02-052021-01-14
THE OMEGA-SPM-DOSE and OMEGA-SPM-PAD: Specialized Pro-Resolving Mediators in Patients With Peripheral Artery Disease
SPM Emulsion, Dose-modality, SPM Softgel, Dose-Modality, Placebo Softgel - Peripheral Arterial Disease, Claudication
Not applicableCompletedUniversity of California, San Francisco302016-03-012021-05-07
Pilot Study to Investigate the Effects of Increased Dialysate Magnesium and Dialysate Bicarbonate on the Calcification Propensity of Serum
Magnesium, Bicarbonate - End Stage Renal Failure on Dialysis, Vascular Calcification
Not applicableCompletedInsel Gruppe AG, University Hospital Bern122015-12-012017-09-26
Orbital Vessel PreparaTIon to MaximIZe Dcb Efficacy in Calcified Below the Knee (BTK) Lesions - A Pilot Study
Peripheral Orbital Atherectomy System, 014 Drug Coated Balloon - PAD, Vascular Calcification
Not applicableCompletedAbbott Medical Devices662015-09-012023-07-18
Optimal Anemia Treatment in End Stage Renal Disease (ERSD)
standard care, Optimal (I. iPTH control: Zemplar®,Mimpara®; phosphorous control: Renvela®, Phoslo®, Osvaren®, Foznol®,Maalox®; calcium control: calcium and vitamin D - Hyperparathyroidism, Secondary
Not applicableUnknownAzienda Ospedaliera Sant'Anna502015-03-012015-09-15
New Biomarkers of Bone Mineral Metabolism as Cardiovascular Risk Factors in Chronic Kidney Disease Patients
Plasma osteoprotegerin level, Plasma fibroblast growth factor 23 level, Vascular calcification score - Chronic Kidney Disease
Not applicableRecruitingUniversity Hospital, Montpellier2502013-03-122022-01-04
A Double Blind Randomized Placebo Trial of Maintenance of Normal Serum Phosphorus in CKD
Calcium acetate, Lanthanum Carbonate, Sevelamer Carbonate - Chronic Kidney Disease
Not applicableCompletedDenver Nephrologists, P.C.1482009-02-012012-10-30
Association of Bone Quality and Quantity With Vascular Calcification
CT of the bones - Vascular Calcification, Atherosclerosis
Not applicableWithdrawnUniversity of Michigan2009-02-012014-06-12
OPG and RANKL Plasma Level After Administration of Unfractionated Heparin (UFH) and Low-Molecular-Weight Heparin (LMWH) in Hemodialysis
law molecular weigth heparin, unfractioned heparin - Renal Failure, Hemodialysis
Not applicableUnknownIRCCS Azienda Ospedaliero-Universitaria di Bologna402008-03-012008-04-30
Arterial Stiffness and Decreased Bone Buffering Capacity in Hemodialysis Patients
high calcium dialysate - Kidney Disease, Hypercalcemia
Not applicableCompletedUniversitaire Ziekenhuizen KU Leuven2007-06-012018-10-17

Narrower conditions

Peripheral Arterial Disease (3)  ·  Renal Insufficiency, Chronic (3)  ·  Cardiovascular Diseases (2)  ·  Coronary Artery Disease (2)  ·  Hyperparathyroidism, Secondary (2)  ·  Renal Insufficiency (2)  ·  Acute Kidney Injury (1)  ·  Anemia (1)  ·  Atherosclerosis (1)  ·  Calcinosis (1)  ·  Diabetic Nephropathies (1)  ·  Hypercalcemia (1)  ·  Intermittent Claudication (1)  ·  Kidney Diseases (1)

Broader conditions

Calcium Metabolism Disorders (19)  ·  Metabolic Diseases (19)  ·  Nutritional and Metabolic Diseases (19)  ·  Calcinosis (18)  ·  Arterial Occlusive Diseases (6)  ·  Arteriosclerosis (6)  ·  Cardiovascular Diseases (6)  ·  Female Urogenital Diseases (6)  ·  Female Urogenital Diseases and Pregnancy Complications (6)  ·  Male Urogenital Diseases (6)  ·  Urogenital Diseases (6)  ·  Urologic Diseases (6)  ·  Kidney Diseases (5)  ·  Vascular Diseases (5)  ·  Pathological Conditions, Signs and Symptoms (4)

Interventions

calcium acetate (2)  ·  LC15-0444 (1)  ·  Nadroparin (1)  ·  Sevelamer (1)  ·  Standard of Care (1)  ·  Vitamin D (1)  ·  lanthanum carbonate (1)

Sponsors

Genesis Medtech Corporation (2)  ·  Abbott Medical Devices (1)  ·  Azienda Ospedaliera Sant'Anna (1)  ·  Bangkok Metropolitan Administration Medical College and Vajira Hospital (1)  ·  Charite University, Berlin, Germany (1)  ·  Denver Nephrologists, P.C. (1)  ·  Emory University (1)  ·  FastWave Medical (1)  ·  Fresenius Medical Care Deutschland GmbH (1)  ·  Hospital Clinic of Barcelona (1)  ·  IRCCS Azienda Ospedaliero-Universitaria di Bologna (1)  ·  Icahn School of Medicine at Mount Sinai (1)  ·  Insel Gruppe AG, University Hospital Bern (1)  ·  Lin Zhao (1)  ·  Universitaire Ziekenhuizen KU Leuven (1)

Countries

United States (5)  ·  China (3)  ·  Germany (2)  ·  Italy (2)  ·  Austria (1)  ·  Belgium (1)  ·  France (1)  ·  Spain (1)  ·  Switzerland (1)  ·  Thailand (1)

Top investigators

Abraham Rincon Bello, Dr. (1)  ·  Antonio Bellasi, MD (1)  ·  Dominik Uehlinger, Prof Dr.med. (1)  ·  Geoffrey A Block, MD (1)  ·  Guy H. Montgomery, Ph.D. (1)  ·  Lin Zhao, Dr (1)  ·  Michael Conte, M.D. (1)  ·  Professor Gunnar Tepe, Dr. (1)  ·  Professor Marianne Brodmann, Dr. (1)  ·  Professor Thomas Zeller, Dr. (1)  ·  Sergio Stefoni, Prof (1)  ·  Thananda Trakarnvanich, M.D. (1)  ·  W. Charles O'Neill, MD (1)  ·  Yebin Jiang, M.D. (1)

Results publications

PMID 16227647, PMID 18007136, PMID 27357090, PMID 31395217, PMID 32553329, PMID 32696697, PMID 34056911, PMID 34697593, PMID 35086385, PMID 36792998, PMID 38189593, PMID 40576086

NIH funding

R01CA251754 (1)